Digipath
Home > Boards > US Listed > Medical - Healthcare >

Gilead Sciences, Inc. (GILD)

GILD RSS Feed
Add GILD Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 12/27/2018 4:25:03 PM - Followers: 109 - Board type: Free - Posts Today: 0
Digipath
GILD
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GILD News: Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Epclusa® (Sofosbuvir/Velpatasvir) 01/08/2019 01:00:00 AM
GILD News: Gilead Sciences & Yuhan Corp. Announce Collaboration & License Agreement to Develop Novel Investigational Treatments for Adva... 01/06/2019 05:30:00 PM
GILD News: Statement of Changes in Beneficial Ownership (4) 01/02/2019 05:23:19 PM
GILD News: Statement of Changes in Beneficial Ownership (4) 01/02/2019 05:19:52 PM
GILD News: Gilead Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7 01/02/2019 09:01:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#2793  Sticky Note GILD’s incoming CEO<—Roche executive, Daniel O’Day (according to WSJ): DewDiligence 12/09/18 08:47:44 PM
#2795   AGEN is one of the 1st to satisfy north40000 12/27/18 04:25:03 PM
#2794   GILD, SRRK ink TGFß/fibrosis drug-discovery collaboration: DewDiligence 12/19/18 08:45:22 AM
#2793   GILD’s incoming CEO<—Roche executive, Daniel O’Day (according to WSJ): DewDiligence 12/09/18 08:47:44 PM
#2792   https://finance.yahoo.com/news/china-national-medical-products-administration-133000565.html http north40000 12/04/18 01:01:49 PM
#2791   China also approved another GILD product, DESCOVY: north40000 12/04/18 12:42:03 PM
#2790   China approves Harvoni: DewDiligence 12/04/18 12:30:01 PM
#2788   GILD’s AASLD lineups… DewDiligence 11/09/18 10:54:22 AM
#2786   ASH abstracts https://ash.confex.com/ash/2018/webprogram/Paper117017.html https: jondoeuk 11/03/18 06:37:20 PM
#2785   GILD -5% on UnitedHealthcare’s incentive for patients to DewDiligence 10/31/18 08:18:38 PM
#2784   GILD 3Q18 CC transcript: DewDiligence 10/26/18 10:55:32 AM
#2783   GILD 3Q18 results—HCV sales=$902M,-10% QoQ: DewDiligence 10/25/18 05:05:27 PM
#2781   Dividend($0.57) and earnings PRs: north40000 10/25/18 04:15:25 PM
#2780   Mavyret’s US new-patient share=53.4%—the highest-ever weekly figure—in th DewDiligence 10/12/18 09:10:20 AM
#2779   GILD will launch Harvoni/Epclusa authorized generics for US DewDiligence 09/24/18 10:00:42 AM
#2778   GILD licenses gene-editing approach to HBV from (private) DewDiligence 09/12/18 11:31:45 AM
#2777   GILD News: Confidential Treatment Order (ct Order) 08/16/2018 05:17:29 PM mick 08/18/18 11:35:59 AM
#2776   GILD News: Gilead Sciences Announces Executive Promotions 08/14/2018 05:00:00 PM mick 08/18/18 11:35:52 AM
#2775   GILD News: Statement of Changes in Beneficial Ownership mick 08/18/18 11:35:38 AM
#2774   GILD News: Current Report Filing (8-k) 08/07/2018 03:52:32 PM mick 08/18/18 11:35:21 AM
#2773   GILD News: Quarterly Report (10-q) 08/06/2018 04:20:27 PM mick 08/18/18 11:35:04 AM
#2772   Gilead Sciences, Inc (GILD) mick 08/18/18 11:34:27 AM
#2771   AH filing yesterday: north40000 08/17/18 09:30:28 AM
#2770   https://www.fiercepharma.com/pharma/louisiana-seeking-comments-netflix-model-for north40000 08/17/18 03:29:11 AM
#2769   Transcript of GILD 2Q18 CC: DewDiligence 07/26/18 11:16:41 AM
#2767   GILD 2Q18 CC slides: DewDiligence 07/25/18 05:10:25 PM
#2766   Curious you would say[muse] that...what about HIV, CAR-T(with north40000 07/25/18 05:08:53 PM
#2765   Musings on John Milligan’s departure: DewDiligence 07/25/18 04:57:49 PM
#2764   CEO, John Milligan leaving at year-end: DewDiligence 07/25/18 04:39:55 PM
#2763   GILD 2Q18 results—total HCV sales $1.0B—(-5% QoQ): DewDiligence 07/25/18 04:39:17 PM
#2762   FDA approves Symtuza for HIV: #msg-142267996. DewDiligence 07/17/18 06:29:07 PM
#2761   Thanks. Very interesting article. wshaw14 06/10/18 04:32:49 PM
#2760   https://www.bloomberg.com/news/articles/2018-06-04/billions-of-fighting-cells-cl north40000 06/06/18 04:36:27 AM
#2759   Epclusa approved in China: DewDiligence 05/30/18 10:19:17 AM
#2758   Weird. Pharma. Didn’t participate. Imun. Hopeful1037 05/21/18 05:02:15 PM
#2757   http://www.otcmarkets.com/stock/GILD mick 05/20/18 07:59:01 PM
#2756   IMHO Gilead is a company with smart leadership wshaw14 05/17/18 12:11:43 AM
#2755   They want to cure AIDS. fink 05/16/18 11:49:19 PM
#2754   Gilead is smart. Keep only what they can wshaw14 05/14/18 10:55:58 PM
#2753   Dew, just one question. Better than a cure? wshaw14 05/06/18 01:35:52 AM
#2752   Lol, anybody thinking HepC is the way to wshaw14 05/06/18 01:32:44 AM
#2751   If you think giving the drug away below fink 05/02/18 11:21:48 PM
#2750   Today's trade off was a mix of data joanne4trade 05/02/18 12:09:30 PM
#2749   Save the rant! Today's selloff is occurring because DewDiligence 05/02/18 10:19:54 AM
#2748   Figures when you have a pharma Company fink 05/02/18 10:09:18 AM
#2747   Transcript of GILD 1Q18 CC: DewDiligence 05/02/18 09:59:39 AM
#2746   GILD 1Q18 CC slides: DewDiligence 05/01/18 04:58:45 PM
#2745   GILD -5%/AH on 1Q18 results—HCV sales=$1.05B: DewDiligence 05/01/18 04:09:04 PM
#2744   Astellas Announces Sale of Certain Agensys Research Facilities wshaw14 04/19/18 06:11:57 AM
#2743   Glad I sold when I did. I will wshaw14 04/12/18 06:53:09 AM
#2742   http://www.stockscores.com/charts/charts/?ticker=GILD mick 04/07/18 02:03:57 PM
PostSubject